Further analyzing TCGA PanCancer Atlas data, we confirmed that, in addition to breast cancer, PTPRZ1 is highly expressed in various cancer types, such as glioma, prostate, lung, esophageal, and select neuroendocrine tumors (Figure S1). This evidence concerns the gene PTPRZ1 and neuroendocrine neoplasm.